These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8641218)

  • 1. 24R,25-dihydroxyvitamin D3 promotes bone formation without causing excessive resorption in hypophosphatemic mice.
    Ono T; Tanaka H; Yamate T; Nagai Y; Nakamura T; Seino Y
    Endocrinology; 1996 Jun; 137(6):2633-7. PubMed ID: 8641218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 1,25-dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice.
    Ecarot B; Glorieux FH; Desbarats M; Travers R; Labelle L
    J Bone Miner Res; 1995 Mar; 10(3):424-31. PubMed ID: 7785464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone-forming ability of 24R,25-dihydroxyvitamin D3 in the hypophosphatemic mouse.
    Yamate T; Tanaka H; Nagai Y; Yamato H; Taniguchi N; Nakamura T; Seino Y
    J Bone Miner Res; 1994 Dec; 9(12):1967-74. PubMed ID: 7872063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse.
    Marie PJ; Travers R; Glorieux FH
    Calcif Tissue Int; 1982 Mar; 34(2):158-64. PubMed ID: 6282410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased intestinal absorption of calcium in young and adult X-linked hypophosphatemic mice after the administration of 1,25-dihydroxyvitamin D3.
    Meyer MH; Meyer RA
    J Bone Miner Res; 1988 Apr; 3(2):151-7. PubMed ID: 3213610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 24R,25-dihydroxyvitamin D3 on the formation and function of osteoclastic cells.
    Yamato H; Okazaki R; Ishii T; Ogata E; Sato T; Kumegawa M; Akaogi K; Taniguchi N; Matsumoto T
    Calcif Tissue Int; 1993 Mar; 52(3):255-60. PubMed ID: 8481842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 24R,25-dihydroxyvitamin D3: an essential vitamin D3 metabolite for both normal bone integrity and healing of tibial fracture in chicks.
    Seo EG; Einhorn TA; Norman AW
    Endocrinology; 1997 Sep; 138(9):3864-72. PubMed ID: 9275076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healing of bone lesions with 1,25-dihydroxyvitamin D3 in the young X-linked hypophosphatemic male mouse.
    Marie PJ; Travers R; Glorieux FH
    Endocrinology; 1982 Sep; 111(3):904-11. PubMed ID: 6896684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of rachitic rat bones to 1,25-dihydroxyvitamin D3: biphasic effects on mineralization and lack of effect on bone resorption.
    Gallagher JA; Beneton M; Harvey L; Lawson DE
    Endocrinology; 1986 Oct; 119(4):1603-9. PubMed ID: 3757903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gautvik KM; Gordeladze JO
    Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased renal catabolism of 1,25-dihydroxyvitamin D3 in murine X-linked hypophosphatemic rickets.
    Tenenhouse HS; Yip A; Jones G
    J Clin Invest; 1988 Feb; 81(2):461-5. PubMed ID: 3339128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 22-oxacalcitriol and 1,25(OH)2D3 on bone metabolism in young X-linked hypophosphatemic male mice.
    Halstead LR; Weinstein RS; Cheng SL; Rifas L; Avioli LV
    Am J Physiol; 1996 Jan; 270(1 Pt 1):E141-7. PubMed ID: 8772486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
    Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
    J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 24R,25-dihydroxyvitamin D3 in combination with 1 alpha-hydroxyvitamin D3 in predialysis renal insufficiency: biochemistry and histomorphometry of cancellous bone.
    Birkenhäger-Frenkel DH; Pols HA; Zeelenberg J; Eijgelsheim JJ; Schot R; Nigg AL; Weimar W; Mulder PG; Birkenhäger JC
    J Bone Miner Res; 1995 Feb; 10(2):197-204. PubMed ID: 7754799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 24,25-dihydroxyvitamin D3 in osteoclasts.
    Matsumoto T; Yamato H; Okazaki R; Kumegawa M; Ogata E
    Proc Soc Exp Biol Med; 1992 Jun; 200(2):161-4. PubMed ID: 1579577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on growth and remodeling of rat bones during hypokinesia (histomorphometric study)].
    Kabitskaia OE; Savik ZF; Kaplanskiĭ AS; Shvets VN; Sergeev IN
    Kosm Biol Aviakosm Med; 1984; 18(4):49-55. PubMed ID: 6332944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term treatment of rats with high dose 1,25-dihydroxyvitamin D3 stimulates bone formation and increases the number of osteoblast precursor cells in bone marrow.
    Erben RG; Scutt AM; Miao D; Kollenkirchen U; Haberey M
    Endocrinology; 1997 Nov; 138(11):4629-35. PubMed ID: 9348188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D-dependent calcium binding proteins in the kidney and intestine of the X-linked hypophosphatemic mouse: changes with age and responses to 1,25-dihydroxycholecalciferol.
    Bruns ME; Christakos S; Huang YC; Meyer MH; Meyer RA
    Endocrinology; 1987 Jul; 121(1):1-6. PubMed ID: 3595516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiestrogens inhibit in vitro bone resorption stimulated by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogs EB1089 and KH1060.
    Vink-van Wijngaarden T; Birkenhäger JC; Kleinekoort WM; van den Bemd GJ; Pols HA; van Leeuwen JP
    Endocrinology; 1995 Feb; 136(2):812-5. PubMed ID: 7835315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.